A damning Bloomberg investigation has exposed a troubling trend where state-run health insurance marketplaces transmitted sensitive user details to advertising titans. The probe revealed that personal data points, including citizenship status and race, were allegedly flowing to third-party trackers without adequate user consent. This digital pipeline allowed tech firms to profile patients, raising significant ethical and privacy concerns for individuals simply seeking essential medical coverage.

Reacting swiftly to the revelations, officials in Virginia and Washington D.C. immediately suspended these data-sharing practices pending a comprehensive internal review. While the full scope of the exposure remains under investigation, this decisive action underscores the urgent need for stricter data governance. Patients expect their most private information to remain secure, not commodified by the hidden machinery of ad tech.